castrate resistant prostate cancer

April 4, 2019

2 Compounds in Coffee Seen to Slow Growth of Prostate Cancer in Early Study

News

Two compounds found in coffee might be able to slow the growth and migration of prostate cancers, a pilot study conducted in drug-resistant cancer cells and a mouse model report. ... Read more

June 8, 2017June 8, 2017

ESSA Pharma Presents Early Results from Clinical Trial Testing EPI-506 in End-stage Prostate Cancer

News

ESSA Pharma‘s small molecule androgen receptor inhibitor, EPI-506 (ralaniten acetate), has shown a favorable safety and tolerability profile among end-stage prostate cancer patients enrolled in a Phase 1/2 trial, as ... Read more

February 20, 2017

Champions Oncology Says New Xenograft Models Will Aid Prostate Cancer Research

News

Champions Oncology has added new cohorts of patient-derived xenograft (PDX) models to its TumorBank, expanding the company’s product line in castrate-resistant prostate cancer (CRPC) and other ailments. The new PDX models ... Read more

October 2, 2014October 2, 2014

Potential New Treatment Strategies for Prostate Cancer presented at ESMO 2014

News

Recent randomized phase III trials data presented at the European Society for Medical Oncology (ESMO) Meeting 2014, showed how patients with prostate cancer exhibit an increase in overall survival upon ... Read more